Daina Graybosch's Stock Ratings

Leerink Partners Analyst

Daina Graybosch is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/31/2024

Overall Average Return

-13.7%

Smart Score

44%

Overall Average Return Percentile

16th

Number of Ratings

56
Buy NowGet Alert
05/15/2024BOLTBuy Now
Bolt Biotherapeutics
$0.7632.14%$3 → $1DowngradeOutperform → Market PerformGet Alert
01/31/2024TSVTBuy Now
2seventy bio
$4.23325.53%$5 → $18UpgradeMarket Perform → OutperformGet Alert
10/30/2023TSVTBuy Now
2seventy bio
$4.23——DowngradeOutperform → Market PerformGet Alert
05/12/2023BOLTBuy Now
Bolt Biotherapeutics
$0.76428.54% → $4UpgradeMarket Perform → OutperformGet Alert
03/30/2023ACLXBuy Now
Arcellx
$52.00-25%$35 → $39MaintainsOutperformGet Alert
02/24/2023NKTRBuy Now
Nektar Therapeutics
$1.28134.38%$5 → $3MaintainsMarket PerformGet Alert
02/03/2023MRKBuy Now
Merck & Co
$125.65-2.9%$120 → $122MaintainsOutperformGet Alert
01/23/2023MRKBuy Now
Merck & Co
$125.65-4.5%$112 → $120MaintainsOutperformGet Alert
01/10/2023TSVTBuy Now
2seventy bio
$4.23703.78%$41 → $34MaintainsOutperformGet Alert
01/06/2023IPSCBuy Now
Century Therapeutics
$2.97371.38%$20 → $14MaintainsOutperformGet Alert
01/06/2023FATEBuy Now
Fate Therapeutics
$3.72168.82%$62 → $10MaintainsOutperformGet Alert
12/13/2022FATEBuy Now
Fate Therapeutics
$3.721566.67%$64 → $62MaintainsOutperformGet Alert
12/12/2022AFMDBuy Now
Affimed
$4.3537.93%$100 → $60MaintainsOutperformGet Alert
11/15/2022IPHABuy Now
Innate Pharma
$2.74228.47%$10 → $9MaintainsOutperformGet Alert
11/08/2022TSVTBuy Now
2seventy bio
$4.23869.27%$42 → $41MaintainsOutperformGet Alert
11/03/2022RCUSBuy Now
Arcus Biosciences
$15.00153.33%$40 → $38MaintainsOutperformGet Alert
09/30/2022MRKBuy Now
Merck & Co
$125.65-12.46%$109 → $110MaintainsOutperformGet Alert
09/27/2022LVTXBuy Now
LAVA Therapeutics
$2.371081.43%$25 → $28MaintainsOutperformGet Alert
09/12/2022MRKBuy Now
Merck & Co
$125.65-13.25%$105 → $109MaintainsOutperformGet Alert
08/29/2022MOLNBuy Now
Molecular Partners
$3.65119.18%$30 → $8DowngradeOutperform → Market PerformGet Alert
08/11/2022BOLTBuy Now
Bolt Biotherapeutics
$0.76428.54%$8 → $4DowngradeOutperform → Market PerformGet Alert
08/04/2022RCUSBuy Now
Arcus Biosciences
$15.00226.67%$66 → $49MaintainsOutperformGet Alert
08/02/2022IPHABuy Now
Innate Pharma
$2.74264.96%$11 → $10MaintainsOutperformGet Alert
07/29/2022MRKBuy Now
Merck & Co
$125.65-16.43%$104 → $105MaintainsOutperformGet Alert
07/29/2022BNTXBuy Now
BioNTech
$100.60122.66%$223 → $224MaintainsOutperformGet Alert
07/18/2022NKTXBuy Now
Nkarta
$6.73345.77% → $30Initiates → OutperformGet Alert
07/13/2022BNTXBuy Now
BioNTech
$100.60121.67%$253 → $223UpgradeMarket Perform → OutperformGet Alert
06/24/2022FSTXBuy Now
F-star Therapeutics
——$21 → $7DowngradeOutperform → Market PerformGet Alert
06/23/2022AFMDBuy Now
Affimed
$4.35106.9%$100 → $90MaintainsOutperformGet Alert
06/23/2022ACLXBuy Now
Arcellx
$52.00-26.92%$47 → $38MaintainsOutperformGet Alert

Recent Analyst Stock Rating News

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion. AMD shares dipped 3.8% to $165.49 on Wednesday.
Crude Oil Down 2%; Alphabet Shares Fall After Q4 Results
U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite falling more than 200 points on Wednesday. The Dow traded up 0.08% to 38,497.13 while the NASDAQ fell 1.41% to 15,291.02. The S&P 500 also fell, dropping, 0.81% to 4,885.29.
Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday
Snap To Surge Around 20%? Here Are 5 Other Price Target Changes For Tuesday
Piper Sandler raised Snap Inc. (NYSE: SNAP) price target from $11 to $12. Piper Sandler analyst Thomas Champion maintained the stock with a Neutral. Snap shares fell 1.4% to close at $10.18 on Monday.
SVB Leerink Cuts Price Target On This Stock By 50%, Also Check Out Some Other Major PT Changes
SVB Leerink cut the price target on Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) from $8 to $4. SVB Leerink analyst Daina Graybosch downgraded the stock from Outperform to Market Perform. Bolt Biotherapeutics shares fell 3.2% to $2.44 in pre-market trading.
Why BioNTech Is Trading Higher Today Following A Stock Upgrade From SVB Securities Analyst
SVB Securities, a division of SVB Financial Group (NASDAQ: SIVB), believes BioNTech SE – ADR (NASDAQ: BNTX) stock is trading below the most negative scenario for the COVID-19 vaccine mar
What Is Happening With Innate Pharma Stock On Friday?
Why Innate Pharma Shares Are Rising On Friday?
So What's Going On With BioNTech's Stock?
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 5.5% at $350 Friday morning after Canaccord Genuity maintained a Buy rating on the stock and raised its price target from $240 to $450.
This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?
Shares of BioNTech SE (NASDAQ: BNTX), which partnered with Pfizer Inc. (NYSE: PFE) in successfully developing a vaccine against the coronavirus, have been gaining ground.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free